世界の多発性硬化症治療薬市場(2014-2018)...市場調査レポートについてご紹介

【英文タイトル】Global Multiple Sclerosis Drugs Market 2014-2018

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Product Profiles
04.1.1 Betaferon/Betaseron/Extavia
04.1.2 Avonex/Rebif
04.1.3 Fampyra
04.1.4 Tecfidera
04.1.5 Tysabri
04.1.6 Gilenya
04.1.7 Copaxone
05. Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06. Introduction
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Rate of Incidence and Prevalence
08. Market Segmentation by Molecule Type
08.1 Global Biologics Market
08.1.1 Market Size and Forecast
08.2 Global Small Molecules Market
08.2.1 Market Size and Forecast
09. Market Segmentation by Route of Administration
09.1 Global Oral Drugs Market
09.1.1 Market Size and Forecast
09.2 Global Parenteral Drugs Market
09.2.1 Market Size and Forecast
10. Geographical Segmentation
10.1 Multiple Sclerosis Market in the US
10.1.1 Market Size and Forecast
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2013
18.2.1 Bayer
18.2.2 Biogen Idec
18.2.3 Merck Serono
18.2.4 Novartis
18.2.5 Teva Pharmaceuticals
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 Bayer
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Business Segmentation
19.1.4 Business Strategy
19.1.5 Sales Segmentation by Business
19.1.6 Sales by Geographical Segmentation
19.1.7 Key Information
19.1.8 SWOT Analysis
19.2 Biogen Idec
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Business Segmentation by Revenue 2013
19.2.4 Geographical Segmentation by Revenue 2013
19.2.5 Business Strategy
19.2.6 Key Developments
19.2.7 SWOT Analysis
19.3 Merck Serono
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Geographical Segmentation by Revenue 2013
19.3.4 Business Strategy
19.3.5 Recent Developments
19.3.6 SWOT Analysis
19.4 Novartis
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Segmentation by Revenue 2013
19.4.4 Business Segmentation by Revenue 2012 and 2013
19.4.5 Sales by Geography
19.4.6 Business Strategy
19.4.7 Key Developments
19.4.8 SWOT Analysis
19.5 Teva Pharmaceuticals
19.5.1 Key Facts
19.5.2 Business Overview
19.5.3 Business Segmentation
19.5.4 Business Segmentation by Revenue 2013
19.5.5 Business Segmentation by Revenue 2012 and 2013
19.5.6 Sales by Geography
19.5.7 Business Strategy
19.5.8 Key Developments
19.5.9 SWOT Analysis
20. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Multiple Sclerosis Drugs Market 2013-2018 (US$ billion)
Exhibit 3: Global Multiple Sclerosis Drugs Market Segmentation by Molecule Type
Exhibit 4: Global Multiple Sclerosis Drugs Market Segmentation by Molecule Type 2013
Exhibit 5: Global Multiple Sclerosis Drugs Market Segmentation by Molecule Type 2018
Exhibit 6: Global Multiple Sclerosis Drugs Market Segmentation by Molecule Type 2013-2018 (US$ billion)
Exhibit 7: Global Multiple Sclerosis Drugs Market Segmentation by Molecule Type 2013-2018 (in percent)
Exhibit 8: Global Biologics Market 2013-2018 (US$ billion)
Exhibit 9: Global Small Molecules Market 2013-2018 (US$ billion)
Exhibit 10: Global Multiple Sclerosis Drugs Market by Route of Administration
Exhibit 11: Global Multiple Sclerosis Drugs Market by Route of Administration 2013
Exhibit 12: Global Multiple Sclerosis Drugs Market by Route of Administration 2018
Exhibit 13: Global Multiple Sclerosis Drugs Market Segmentation by Route of Administration 2013-2018 (US$ billion)
Exhibit 14: Global Multiple Sclerosis Drugs Market Segmentation by Route of Administration 2013-2018 (in percent)
Exhibit 15: Global Oral Drugs Market 2013-2018 (US$ billion)
Exhibit 16: Global Parenteral Drugs Market 2013-2018 (US$ billion)
Exhibit 17: Global Multiple Sclerosis Drugs Market by Geography 2013
Exhibit 18: Multiple Sclerosis Market in the US 2013-2018 (US$ billion)
Exhibit 19: Global Multiple Sclerosis Drugs Market by Vendor Segmentation 2013
Exhibit 20: Global Sales Comparison of Betaseron/Betaferon 2010-2013 (US$ million)
Exhibit 21: Sales of Avonex 2011-2013 (US$ million)
Exhibit 22: Sales of Tysabri 2011-2013 (US$ million)
Exhibit 23: Sales of Fampyra 2011-2013 (US$ million)
Exhibit 24: Sales Comparison of Avonex, Tysabri and Fampyra 2011-2013 (US$ million)
Exhibit 25: Sales of Rebif 2010-2013 (US$ million)
Exhibit 26: Sales of Rebif in North America 2010-2013 (US$ million)
Exhibit 27: Sales of Rebif in Europe 2010-2013 (US$ million)
Exhibit 28: Sales of Rebif in Emerging Markets and RoW 2010-2013 (US$ million)
Exhibit 29: Geography-wise Sales of Rebif 2010-2013 (US$ million)
Exhibit 30: Sales of Gilenya 2010-2013 (US$ million)
Exhibit 31: Sales of Extavia 2010-2013 (US$ million)
Exhibit 32: Sales of Gilenya and Extavia 2010-2013 (US$ million)
Exhibit 33: Quarter-wise Sales of Copaxone 2011-2013 (US$ million)
Exhibit 34: Quarter-wise Sales of Copaxone in the US 2011-2013 (US$ million)
Exhibit 35: Quarter-wise Sales of Copaxone Outside the US 2011-2013 (US$ million)
Exhibit 36: Business Segmentation of Bayer AG 2013
Exhibit 37: Sales Comparison of Bayer AG by Business Segment 2012 and 2013 (US$ million)
Exhibit 38: Sales Segmentation of Bayer AG by Geography 2013
Exhibit 39: Biogen Idec: Business Segmentation by Revenue 2013
Exhibit 40: Biogen Idec: Geographical Segmentation by Revenue 2013
Exhibit 41: Merck Serono: Geographical Segmentation by Revenue 2013
Exhibit 42: Novartis AG: Business Segmentation by Revenue 2013
Exhibit 43: Novartis AG: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 44: Novartis AG: Sales by Geography 2013
Exhibit 45: Teva Pharmaceutical Industries Ltd.: Business Segmentation
Exhibit 46: Teva Pharmaceutical Industries Ltd.: Business Segmentation by Revenue 2013
Exhibit 47: Teva Pharmaceutical Industries Ltd.: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 48: Teva Pharmaceutical Industries Ltd.: Sales by Geography 2013


【レポート販売概要】

■ タイトル:世界の多発性硬化症治療薬市場(2014-2018)
■ 英文:Global Multiple Sclerosis Drugs Market 2014-2018
■ 発行日:2014年8月20日
■ 調査会社:Technavio
■ 商品コード:IRTNTR3981
■ 調査対象地域:グローバル
  • インメモリOLAPデータベースの世界市場2016-2020
    About In-Memory Database The in-memory database is one of the subcomponents of IMDM, the other subcomponent being in-memory data grid (IMDG). IMDM and in-memory application platform (IMAP) are the components of in-memory computing (IMC), which form the base of this technology. The primary purpose of in-memory processing technology is to enable real-time analyses and allow organizations to store da …
  • 紙用顔料の世界市場2019-2023
    102 pages, November 2018 About this market Increasing adoption of UWF paper in packaging to gain traction in the global paper pigments market. The advent of industry 4.0 has led to technological advances and increased adoption of sustainable packaging solutions. Technavio’s analysts have predicted that the Paper Pigments market will register a CAGR of around 4% by 2023. Market Overview Growing con …
  • 世界的なナノ複合材料の世界市場分析:製品別(カーボンナノチューブ、ナノクレー、金属/金属酸化物、セラミックス、その他)、用途別(梱包、自動車、エレクトロニクス、電気、航空、エネルギー、建設、軍用、その他)、セグメント予測
    The global nanocomposites market size is expected to reach USD 7.48 billion by 2022, according to a new report by Grand View Research, Inc. Growing demand for nanocomposites in the automobile industry, increased application of nanocomposites in building and construction, high volume consumption in electronics and semiconductors are some of the major factors that have been driving the market. Howev …
  • データベース暗号化の世界市場:透過的暗号化、ファイルシステム暗号化、アプリケーションレベル暗号化、列レベル暗号化、ハッシュ、鍵管理
    The database encryption market is expected to grow from USD 261.8 Million in 2015 to USD 968.3 Million by 2020, at a Compound Annual Growth Rate (CAGR) of 29.9%. In 1961, a computer based login and password was developed to allow more users to work on a single machine. This increased the risk of data leakage due to which, in 1979, the Data Encryption Standard was launched. In 1996, another standar …
  • 動物用駆虫薬の世界市場2017-2021
    About Animal Parasiticides Veterinary parasiticides or antiparasitics are products that kill parasites that infest livestock, pets, and other animals. The global animal parasiticides market is expected to grow at a moderate pace driven by the rise in demand for animal proteins and the increased focus on food safety. The increase in animal population will also help boost market growth. Bayer Health …
  • スキンライトナーの世界市場2016-2020
    About Skin Lightening Products Skin lightening products are used to lighten skin tone, provide an even complexion, or even suppress or lessen melanin production in the body to avoid further darkening of the skin. The desire for radiant, luminous skin with no dark spots, sun damage, or acne scars is increasing rapidly across the world. In order to achieve flawless skin, consumers are increasingly i …
  • 自動車用パワーステアリングギヤの世界市場
    About Automotive Power Steering GearsAutomotive power steering helps the driver to steer the wheels by controlling the steering effort on the wheel. In power steering, electric motors help the steering motion instead of hydraulic systems. Technavio’s analysts forecast the global automotive power steering gears market to grow at a CAGR of 3.94% during the period 2017-2021. [Covered in this report] …
  • 世界のABS樹脂市場(2014-2018)
    About ABS ABS is an engineering thermoplastic resin composed of styrene, butadiene, and acrylonitrile monomers. Being composed mainly of styrene, and varying ratios of butadiene and acrylonitrile, ABS material can be readily modified in terms of rigidity, hardness and heat resistance, and toughness by varying the monomer proportions. The unique material properties of ABS include impact resistance, …
  • グレインミル製品の世界市場:製品種類別(小麦、米、その他)、流通経路別(スーパーマーケット/ハイパーマーケット、食料品店、オンラインストア)
    Flour is mainly obtained by grinding wheat, maize, rice, and other cereals. Wheat is the grain most commonly used to make flour, accounting nearly 84.5% of the total content, followed by maize (a staple in the Americas) and rice. Wheat is the main ingredient used in the production of bread, which is a staple food for many cultures. Flour contains a high proportion of starch, which is a subset of c …
  • BRIC(ブラジル・ロシア・インド・中国)の疼痛管理市場
    BRIC Pain Management Devices Market Outlook to 2021 Summary GlobalData’s new report, "BRIC Pain Management Devices Market Outlook to 2021", provides key market data on the BRIC Pain Management Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market. The report also provides company shares and distribution sha …
  • Child Abuse:グローバル臨床試験レビューH2, 2013
    Child Abuse Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Child Abuse Global Clinical Trials Review, H2, 2013" provides data on the Child Abuse clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Child Abuse. It includes an overview of the trial numbers and their recruitment status as per the site of …
  • スマートテキスタイルの世界市場2016-2023
    In this report we identify the opportunities emerging from commercialization of smart textiles. These include textiles that are (1) fabricated from smart materials or (2) utilize sensing devices that are seamlessly integrated into the textile. The smart textile sector has taken off in the past few years, driven by the keen interest in the Internet-of-things (IoT) and enabled by the latest smart ma …
  • チオフェンの世界市場
    Thiophene (CAS 110-02-1) Market Research Report 2014 presents comprehensive data on thiophene markets globally and regionally (Europe, Asia, North America etc.) The report includes thiophene description, covers its application areas and related patterns. It overviews thiophene market, names thiophene producers and indicates its suppliers. Besides, the report provides thiophene prices in regional m …
  • 血栓塞栓症(Thromboembolism):世界の治験レビュー(2015年上半期版)
    Thromboembolism Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Thromboembolism Global Clinical Trials Review, H1, 2015" provides data on the Thromboembolism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Thromboembolism. It includes an overview of the trial numbers and their recruitment status as …
  • アルミニウム箔パッケージングの世界市場2016-2020
    About Aluminum Foils Aluminum foils are produced by continuous casting and cold rolling of aluminum sheets. They are prepared in thin metal leaves and can be used to wrap around any product for packaging. They act as a major barrier to bacteria, oxygen, and moisture. These are used in the pharmaceutical and food and beverage sectors. Technavio’s analysts forecast the global aluminium foil packagin …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。